Oxford BioMedica plc (LON:OXB) insider Lorenzo Tallarigo bought 79,988 shares of the firm’s stock in a transaction that occurred on Monday, September 26th. The stock was acquired at an average cost of GBX 3 ($0.04) per share, with a total value of £2,399.64 ($3,132.28).
Shares of Oxford BioMedica plc (LON:OXB) opened at 3.30 on Wednesday. The firm’s market cap is GBX 87.94 million. Oxford BioMedica plc has a 52 week low of GBX 3.19 and a 52 week high of GBX 8.45. The firm has a 50-day moving average of GBX 3.99 and a 200-day moving average of GBX 4.90.
About Oxford BioMedica plc
Oxford BioMedica plc is a gene and cell therapy company. The Company is engaged in lentiviral vector and cell therapy research, development and production. The Company’s segments include Partnering, and R&D. The Partnering segment provides lentiviral vector bioprocessing and process development services to partners.
Receive News & Ratings for Oxford BioMedica plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica plc and related companies with MarketBeat.com's FREE daily email newsletter.